{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T22:26:38Z","timestamp":1770503198451,"version":"3.49.0"},"reference-count":221,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2009,6,26]],"date-time":"2009-06-26T00:00:00Z","timestamp":1245974400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1007\/s00228-009-0682-z","type":"journal-article","created":{"date-parts":[[2009,6,25]],"date-time":"2009-06-25T08:11:13Z","timestamp":1245917473000},"page":"853-871","source":"Crossref","is-referenced-by-count":101,"title":["Inhaled corticosteroids as combination therapy with \u03b2-adrenergic agonists in airways disease: present and future"],"prefix":"10.1007","volume":"65","author":[{"given":"Kian Fan","family":"Chung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaetano","family":"Caramori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian M.","family":"Adcock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,6,26]]},"reference":[{"key":"682_CR1","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jaci.2006.01.032","volume":"117","author":"K Ito","year":"2006","unstructured":"Ito K, Chung KF, Adcock IM (2006) Update on glucocorticoid action and resistance. J Allergy Clin Immunol 117:522\u2013543","journal-title":"J Allergy Clin Immunol"},{"key":"682_CR2","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1210\/me.2007-0101","volume":"21","author":"NL Weigel","year":"2007","unstructured":"Weigel NL, Moore NL (2007) Steroid receptor phosphorylation: a key modulator of multiple receptor functions. Mol Endocrinol 21:2311\u20132319","journal-title":"Mol Endocrinol"},{"key":"682_CR3","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1378\/chest.08-0440","volume":"134","author":"IM Adcock","year":"2008","unstructured":"Adcock IM, Barnes PJ (2008) Molecular mechanisms of corticosteroid resistance. Chest 134:394\u2013401","journal-title":"Chest"},{"key":"682_CR4","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2007.01.015","volume":"128","author":"B Li","year":"2007","unstructured":"Li B, Carey M, Workman JL (2007) The role of chromatin during transcription. Cell 128:707\u2013719","journal-title":"Cell"},{"key":"682_CR5","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1371\/journal.pgen.0030094","volume":"3","author":"AY So","year":"2007","unstructured":"So AY, Chaivorapol C, Bolton EC, Li H, Yamamoto KR (2007) Determinants of cell- and gene-specific transcriptional regulation by the glucocorticoid receptor. PLoS Genet 3:e94","journal-title":"PLoS Genet"},{"key":"682_CR6","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1172\/JCI21759","volume":"116","author":"E Xystrakis","year":"2006","unstructured":"Xystrakis E, Kusumakar S, Boswell S, Peek E, Urry Z, Richards DF, Adikibi T, Pridgeon C, Dallman M, Loke TK et al (2006) Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J Clin Invest 116:146\u2013155","journal-title":"J Clin Invest"},{"key":"682_CR7","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jaci.2006.01.032","volume":"117","author":"K Ito","year":"2006","unstructured":"Ito K, Chung KF, Adcock IM (2006) Update on glucocorticoid action and resistance. J Allergy Clin Immunol 117:522\u2013543","journal-title":"J Allergy Clin Immunol"},{"key":"682_CR8","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ejphar.2007.11.076","volume":"583","author":"BK De","year":"2008","unstructured":"De BK, Van CK, Meijer OC, Haegeman G (2008) Selective transrepression versus transactivation mechanisms by glucocorticoid receptor modulators in stress and immune systems. Eur J Pharmacol 583:290\u2013302","journal-title":"Eur J Pharmacol"},{"key":"682_CR9","doi-asserted-by":"crossref","first-page":"478","DOI":"10.4049\/jimmunol.175.1.478","volume":"175","author":"M Nie","year":"2005","unstructured":"Nie M, Knox AJ, Pang L (2005) Beta2-adrenoceptor agonists, like glucocorticoids, repress eotaxin gene transcription by selective inhibition of histone H4 acetylation. J Immunol 175:478\u2013486","journal-title":"J Immunol"},{"key":"682_CR10","doi-asserted-by":"crossref","first-page":"25765","DOI":"10.1074\/jbc.R700053200","volume":"283","author":"AR Clark","year":"2008","unstructured":"Clark AR, Martins JR, Tchen CR (2008) Role of dual specificity phosphatases in biological responses to glucocorticoids. J Biol Chem 283:25765\u201325769","journal-title":"J Biol Chem"},{"key":"682_CR11","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/thx.2007.090027","volume":"63","author":"P Bhavsar","year":"2008","unstructured":"Bhavsar P, Hew M, Khorasani N, Torrego A, Barnes PJ, Adcock I, Chung KF (2008) Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma. Thorax 63:784\u2013790","journal-title":"Thorax"},{"key":"682_CR12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/10409230490513991","volume":"39","author":"S Meyer","year":"2004","unstructured":"Meyer S, Temme C, Wahle E (2004) Messenger RNA turnover in eukaryotes: pathways and enzymes. Crit Rev Biochem Mol Biol 39:197\u2013216","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"682_CR13","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1183\/09031936.06.00048605","volume":"27","author":"G Horvath","year":"2006","unstructured":"Horvath G, Wanner A (2006) Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma. Eur Respir J 27:172\u2013187","journal-title":"Eur Respir J"},{"key":"682_CR14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nrd1283","volume":"3","author":"AW Norman","year":"2004","unstructured":"Norman AW, Mizwicki MT, Norman DP (2004) Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model. Nat Rev Drug Discov 3:27\u201341","journal-title":"Nat Rev Drug Discov"},{"key":"682_CR15","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/sj.bjp.0703272","volume":"130","author":"JD Croxtall","year":"2000","unstructured":"Croxtall JD, Choudhury Q, Flower RJ (2000) Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor-dependent, transcription-independent mechanism. Br J Pharmacol 130:289\u2013298","journal-title":"Br J Pharmacol"},{"key":"682_CR16","first-page":"890","volume":"145","author":"PK Jeffery","year":"1992","unstructured":"Jeffery PK, Godfrey RW, Adelroth E, Nelson F, Rogers A, Johansson SA (1992) Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study. Am Rev Respir Dis 145:890\u2013899","journal-title":"A quantitative light and electron microscopic study. Am Rev Respir Dis"},{"key":"682_CR17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1164\/ajrccm\/142.1.91","volume":"142","author":"E Adelroth","year":"1990","unstructured":"Adelroth E, Rosenhall L, Johansson S-A, Linden M, Venge P (1990) Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage: the effects of antiasthmatic treatment with budesonide or terbutaline. Am Rev Respir Dis 142:91\u201399","journal-title":"Am Rev Respir Dis"},{"key":"682_CR18","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0091-6749(06)80008-4","volume":"90","author":"LA Laitinen","year":"1992","unstructured":"Laitinen LA, Laitinen A, Haahtele T (1992) A comparative study of the effects of an inhaled corticosteroid, budesemide, and of a \u03b22-agonist, terbutaline, on airway inflammation in newly diagnosed asthma. J Allergy Clin Immunol 90:32\u201342","journal-title":"J Allergy Clin Immunol"},{"key":"682_CR19","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1398-9995.1988.tb00901.x","volume":"43","author":"LC Laursen","year":"1988","unstructured":"Laursen LC, Taudorf E, Borgeskov S, Kobayasi T, Jensen H, Weeke B (1988) Fiberoptic bronchoscopy and bronchial mucosal biopsies in asthmatics undergoing long-term high-dose budesonide aerosol treatment. Allergy 43:284\u2013288","journal-title":"Allergy"},{"key":"682_CR20","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1164\/ajrccm\/145.3.669","volume":"145","author":"R Djukanovic","year":"1992","unstructured":"Djukanovic R, Wilson JW, Britten KM, Wilson SJ, Walls AF, Roche WR, Howarth PH, Holgate ST (1992) The effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis 145:669\u2013674","journal-title":"Am Rev Respir Dis"},{"key":"682_CR21","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/thx.54.5.403","volume":"54","author":"EL Rensen van","year":"1999","unstructured":"van Rensen EL, Straathof KC, Veselic-Charvat MA, Zwinderman AH, Bel EH, Sterk PJ (1999) Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma. Thorax 54:403\u2013408","journal-title":"Thorax"},{"key":"682_CR22","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1164\/ajrccm.155.6.9196087","volume":"155","author":"D Olivieri","year":"1997","unstructured":"Olivieri D, Chetta A, Del Donno M, Bertorelli G, Casalini A, Pesci A, Testi R, Foresi A (1997) Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study. Am J Respir Crit Care Med 155:1864\u20131871","journal-title":"Am J Respir Crit Care Med"},{"key":"682_CR23","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/thx.54.4.289","volume":"54","author":"BE Orsida","year":"1999","unstructured":"Orsida BE, Li X, Hickey B, Thien F, Wilson JW, Walters EH (1999) Vascularity in asthmatic airways: relation to inhaled steroid dose. Thorax 54:289\u2013295","journal-title":"Thorax"},{"key":"682_CR24","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1164\/ajrccm.161.1.9905068","volume":"161","author":"JL Brieva","year":"2000","unstructured":"Brieva JL, Danta I, Wanner A (2000) Effect of an inhaled glucocorticosteroid on airway mucosal blood flow in mild asthma. Am J Respir Crit Care Med 161:293\u2013296","journal-title":"Am J Respir Crit Care Med"},{"key":"682_CR25","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1164\/ajrccm.159.4.9806052","volume":"159","author":"JK Sont","year":"1999","unstructured":"Sont JK, Willems LN, Bel EH, van Krieken JH, Vandenbroucke JP, Sterk PJ (1999) Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med 159:1043\u20131051","journal-title":"Am J Respir Crit Care Med"},{"key":"682_CR26","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2222.1992.tb00161.x","volume":"22","author":"PG Gibson","year":"1992","unstructured":"Gibson PG, Wong BJ, Hepperle MJ, Kline PA, Girgis-Gabardo A, Guyatt G, Dolovich J, Denburg JA, Ramsdale EH, Hargreave FE (1992) A research method to induce and examine a mild exacerbation of asthma by withdrawal of inhaled corticosteroid. Clin Exp Allergy 22:525\u2013532","journal-title":"Clin Exp Allergy"},{"key":"682_CR27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1164\/ajrccm.160.1.9809104","volume":"160","author":"C Veen in\u2019t","year":"1999","unstructured":"in\u2019t Veen C, Smits HH, Hiemstra PS, Zwinderman AE, Sterk PJ, Bel EH (1999) Lung function and sputum characteristics of patients with severe asthma during an induced exacerbation by double-blind steroid withdrawal. Am J Respir Crit Care Med 160:93\u201399","journal-title":"Am J Respir Crit Care Med"},{"key":"682_CR28","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1056\/NEJM199503303321307","volume":"332","author":"PJ Barnes","year":"1995","unstructured":"Barnes PJ (1995) Inhaled glucocorticoids for asthma. N Engl J Med 332:868\u2013875","journal-title":"N Engl J Med"},{"key":"682_CR29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/pupt.2001.0312","volume":"15","author":"SP Umland","year":"2002","unstructured":"Umland SP, Schleimer RP, Johnston SL (2002) Review of the molecular and cellular mechanisms of action of glucocorticoids for use in asthma. Pulm Pharmacol Ther 15:35\u201350","journal-title":"Pulm Pharmacol Ther"},{"key":"682_CR30","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/0091-6749(94)90333-6","volume":"94","author":"RP Schleimer","year":"1994","unstructured":"Schleimer RP, Bochner BS (1994) The effects of glucocorticoids on human eosinophils. J Allergy Clin Immunol 94:1202\u20131213","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl 1","key":"682_CR31","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1007\/BF01844196","volume":"45","author":"RP Schleimer","year":"1993","unstructured":"Schleimer RP (1993) An overview of glucocorticoid anti-inflammatory actions. Eur J Clin Pharmacol 45(Suppl 1):S3\u2013S7","journal-title":"Eur J Clin Pharmacol"},{"issue":"Suppl 2","key":"682_CR32","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000195109","volume":"50","author":"SP Peters","year":"1986","unstructured":"Peters SP, Naclerio RM, Schleimer RP, MacGlashan DW Jr, Pipkorn U, Lichtenstein LM (1986) The pharmacologic control of mediator release from human basophils and mast cells. Respiration 50(Suppl 2):116\u2013122","journal-title":"Respiration"},{"key":"682_CR33","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1164\/ajrccm\/145.3.669","volume":"145","author":"R Djukanovic","year":"1992","unstructured":"Djukanovic R, Wilson JW, Britten KM, Wilson SJ, Walls AF, Roche WR, Howarth PH, Holgate ST (1992) Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis 145:669\u2013674","journal-title":"Am Rev Respir Dis"},{"key":"682_CR34","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0091-6749(97)70252-5","volume":"100","author":"M Majori","year":"1997","unstructured":"Majori M, Piccoli ML, Bertacco S, Cuomo A, Cantini L, Pesci A (1997) Inhaled beclomethasone dipropionate downregulates CD4 and CD8 T-lymphocyte activation in peripheral blood of patients with asthma. J Allergy Clin Immunol 100:379\u2013382","journal-title":"J Allergy Clin Immunol"},{"key":"682_CR35","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1164\/ajrccm.149.1.8111605","volume":"149","author":"JW Wilson","year":"1994","unstructured":"Wilson JW, Djukanovic R, Howarth PH, Holgate ST (1994) Inhaled beclomethasone dipropionate downregulates airway lymphocyte activation in atopic asthma. Am J Respir Crit Care Med 149:86\u201390","journal-title":"Am J Respir Crit Care Med"},{"key":"682_CR36","first-page":"3078","volume":"149","author":"L Borish","year":"1992","unstructured":"Borish L, Mascali JJ, Dishuck J, Beam WR, Martin RJ, Rosenwasser LJ (1992) Detection of alveolar macrophage-derived IL-1 beta in asthma. Inhibition with corticosteroids. J Immunol 149:3078\u20133082","journal-title":"Inhibition with corticosteroids. J Immunol"},{"key":"682_CR37","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1164\/ajrccm.149.4.8143061","volume":"149","author":"R Dworski","year":"1994","unstructured":"Dworski R, Fitzgerald GA, Oates JA, Sheller JR (1994) Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am J Respir Crit Care Med 149:953\u2013959","journal-title":"Am J Respir Crit Care Med"},{"key":"682_CR38","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1164\/ajrccm.156.3.9610046","volume":"156","author":"SE Wenzel","year":"1997","unstructured":"Wenzel SE, Szefler SJ, Leung DYM, Sloan SI, Rex MD, Martin RJ (1997) Bronchoscopic evaluation of severe asthma: persistent inflammation associated with high dose glucocorticoids. Amer J Respir Crit Care Med 156:737\u2013743","journal-title":"Amer J Respir Crit Care Med"},{"key":"682_CR39","first-page":"4719","volume":"154","author":"G Cox","year":"1995","unstructured":"Cox G (1995) Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes. J Immunol 154:4719\u20134725","journal-title":"Separation of survival and activation outcomes. J Immunol"},{"key":"682_CR40","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0022-3565(25)22251-0","volume":"250","author":"RP Schleimer","year":"1989","unstructured":"Schleimer RP, Freeland HS, Peters SP, Brown KE, Derse CP (1989) An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils. J Pharmacol Exp Ther 250:598\u2013605","journal-title":"J Pharmacol Exp Ther"},{"key":"682_CR41","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1183\/09031936.96.09020196","volume":"9","author":"SA Kharitonov","year":"1996","unstructured":"Kharitonov SA, Yates DH, Chung KF, Barnes PJ (1996) Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients. Eur Respir J 9:196\u2013201","journal-title":"Eur Respir J"},{"key":"682_CR42","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1136\/thx.54.9.825","volume":"54","author":"KF Chung","year":"1999","unstructured":"Chung KF, Barnes PJ (1999) Cytokines in asthma. Thorax 54:825\u2013857","journal-title":"Thorax"},{"key":"682_CR43","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/9780470754221.ch14","volume-title":"Airway smooth muscle in asthma and COPD: biology and pharmacology","author":"KF Chung","year":"2008","unstructured":"Chung KF (2008) Asthma treatments: effects on the airway smooth muscle. In: Chung KF (ed) Airway smooth muscle in asthma and COPD: biology and pharmacology. John Wiley & Sons, Chichester, pp 277\u2013302"},{"key":"682_CR44","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1164\/ajrccm.157.1.9703079","volume":"157","author":"M John","year":"1998","unstructured":"John M, Lim S, Seybold J, Jose P, Robichaud A, O\u2019Connor B, Barnes PJ, Chung KF (1998) Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1alpha, granulocyte-macrophage colony-stimulating factor, and interferon-gamma release from alveolar macrophages in asthma. Am J Respir Crit Care Med 157:256\u2013262","journal-title":"Am J Respir Crit Care Med"},{"key":"682_CR45","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1136\/thx.52.5.407","volume":"52","author":"AR Sousa","year":"1997","unstructured":"Sousa AR, Trigg CJ, Lane SJ, Hawksworth R, Nakhosteen JA, Poston RN, Lee TH (1997) Effect of inhaled glucocorticoids on IL-1 beta and IL-1 receptor antagonist (IL-1 ra) expression in asthmatic bronchial epithelium. Thorax 52:407\u2013410","journal-title":"Thorax"},{"key":"682_CR46","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/thx.41.9.657","volume":"41","author":"KF Chung","year":"1986","unstructured":"Chung KF (1986) Role played by inflammation in the hyperreactivity of the airways in asthma. Thorax 41:657\u2013662","journal-title":"Thorax"},{"key":"682_CR47","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1164\/ajrccm\/142.4.832","volume":"142","author":"EF Juniper","year":"1990","unstructured":"Juniper EF, Kline PA, Vanzieleghem MA, Ramsdale EH, O\u2019Byrne PM, Hargreave FE (1990) Effect of a long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthma. Am Rev Respir Dis 142:832\u2013836","journal-title":"Am Rev Respir Dis"},{"key":"682_CR48","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/thorax.57.4.309","volume":"57","author":"C Ward","year":"2002","unstructured":"Ward C, Pais M, Bish R, Reid D, Feltis B, Johns D, Walters EH (2002) Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma. Thorax 57:309\u2013316","journal-title":"Thorax"},{"key":"682_CR49","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1136\/thx.46.11.811","volume":"46","author":"AS Vathenen","year":"1991","unstructured":"Vathenen AS, Knox AJ, Wisniewski A, Tattersfield AE (1991) Effect of inhaled budesonide on bronchial reactivity to histamine, exercise and encepnic dry air hyperventilation in patients with asthma. Thorax 46:811\u2013816","journal-title":"Thorax"},{"key":"682_CR50","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1164\/ajrccm\/141.3_Pt_2.S97a","volume":"141","author":"PJ Barnes","year":"1990","unstructured":"Barnes PJ (1990) Effect of corticosteroids on airway hyperresponsiveness. Am Rev Respir Dis 141:S70\u2013S76","journal-title":"Am Rev Respir Dis"},{"key":"682_CR51","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1164\/ajrccm.164.7.2102135","volume":"164","author":"M Berge van den","year":"2001","unstructured":"van den Berge M, Kerstjens HA, Meijer RJ, de Reus DM, Koeter GH, Kauffman HF, Postma DS (2001) Corticosteroid-induced improvement in the PC20 of adenosine monophosphate is more closely associated with reduction in airway inflammation than improvement in the PC20 of methacholine. Am J Respir Crit Care Med 164:1127\u20131132","journal-title":"Am J Respir Crit Care Med"},{"key":"682_CR52","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1164\/ajrccm\/143.1.109","volume":"143","author":"EH Bel","year":"1991","unstructured":"Bel EH, Timmers MC, Zwinderman AH, Dijkman JH, Sterk PJ (1991) The effect of inhaled corticosteroids on the maximal degree of airway narrowing to methacholine in asthmatic subjects. Am Rev Respir Dis 143:109\u2013113","journal-title":"Am Rev Respir Dis"},{"key":"682_CR53","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1164\/ajrccm\/143.6.1317","volume":"143","author":"AS Vathenen","year":"1991","unstructured":"Vathenen AS, Knox AJ, Wisniewski A, Tattersfield AE (1991) Time course of change in bronchial reactivity with an inhaled corticosteroid in asthma. Am Rev Respir Dis 143:1317\u20131321","journal-title":"Am Rev Respir Dis"},{"key":"682_CR54","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1056\/NEJM199409153311103","volume":"331","author":"T Haahtela","year":"1994","unstructured":"Haahtela T, Jarvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, Nikander K, Persson T, Selroos O, Sovijarvi A et al (1994) Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 331:700\u2013705","journal-title":"N Engl J Med"},{"key":"682_CR55","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/0091-6749(91)90006-A","volume":"87","author":"EF Juniper","year":"1991","unstructured":"Juniper EF, Kline PA, Vanzieleghem MA, Hargreave FE (1991) Reduction of budesonide after a year of increased use: a randomized controlled trial to evaluate whether improvements in airway responsiveness and clinical asthma are maintained. J Allergy Clin Immunol 87:483\u2013489","journal-title":"J Allergy Clin Immunol"},{"key":"682_CR56","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1056\/NEJM200007273430407","volume":"343","author":"PJ Barnes","year":"2000","unstructured":"Barnes PJ (2000) Chronic obstructive pulmonary disease. N Engl J Med 343:269\u2013280","journal-title":"N Engl J Med"},{"key":"682_CR57","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1164\/rccm.200703-456SO","volume":"176","author":"KF Rabe","year":"2007","unstructured":"Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, Van Weel C et al (2007) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176:532\u2013555","journal-title":"Am J Respir Crit Care Med"},{"key":"682_CR58","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1056\/NEJMoa032158","volume":"350","author":"JC Hogg","year":"2004","unstructured":"Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO et al (2004) The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 350:2645\u20132653","journal-title":"N Engl J Med"},{"key":"682_CR59","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1164\/ajrccm.163.6.2009116","volume":"163","author":"M Saetta","year":"2001","unstructured":"Saetta M, Turato G, Maestrelli P, Mapp CE, Fabbri LM (2001) Cellular and structural bases of chronic obstructive pulmonary disease. Am. J Respir Crit Care Med 163:1304\u20131309","journal-title":"Am. J Respir Crit Care Med"},{"key":"682_CR60","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1183\/09031936.00018908","volume":"31","author":"KF Chung","year":"2008","unstructured":"Chung KF, Adcock IM (2008) Multi-faceted mechanism in COPD: inflammation, immunity and tissue repair and destruction. Eur Respir J 31:1334\u20131356","journal-title":"Eur Respir J"},{"key":"682_CR61","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2466-5-3","volume":"5","author":"WQ Gan","year":"2005","unstructured":"Gan WQ, Man P, Sin DD (2005) Effects of inhaled corticosteroids on sputum cell counts in stable chronic obstructive pulmonary disease: a systematic review and a meta-analysis. BMC Pulm Med 5:3\u20133","journal-title":"BMC Pulm Med"},{"key":"682_CR62","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/15412550801941000","volume":"5","author":"M Boorsma","year":"2008","unstructured":"Boorsma M, Lutter R, van de Pol MA, Out TA, Jansen HM, Jonkers RE (2008) Long-term effects of budesonide on inflammatory status in COPD. COPD 5:97\u2013104","journal-title":"COPD"},{"key":"682_CR63","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1164\/ajrccm.155.5.9154853","volume":"155","author":"P Chanez","year":"1997","unstructured":"Chanez P, Vignola AM, O\u2019Shaugnessy T, Enander I, Li D, Jeffery PK, Bousquet J (1997) Corticosteroid reversibility in COPD is related to features of asthma. Am J Respir Crit Care Med 155:1529\u20131534","journal-title":"Am J Respir Crit Care Med"},{"key":"682_CR64","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0140-6736(00)02872-5","volume":"356","author":"CE Brightling","year":"2000","unstructured":"Brightling CE, Monteiro W, Ward R, Parker D, Morgan MD, Wardlaw AJ, Pavord ID (2000) Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 356:1480\u20131485","journal-title":"Lancet"},{"key":"682_CR65","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1164\/rccm.2105025","volume":"165","author":"KL Hattotuwa","year":"2002","unstructured":"Hattotuwa KL, Gizycki MJ, Ansari TW, Jeffery PK, Barnes NC (2002) The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study. Am J Respir Crit Care Med 165:1592\u20131596","journal-title":"Am J Respir Crit Care Med"},{"key":"682_CR66","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1136\/thorax.57.9.799","volume":"57","author":"MJ Gizycki","year":"2002","unstructured":"Gizycki MJ, Hattotuwa KL, Barnes N, Jeffery PK (2002) Effects of fluticasone propionate on inflammatory cells in COPD: an ultrastructural examination of endobronchial biopsy tissue. Thorax 57:799\u2013803","journal-title":"Thorax"},{"key":"682_CR67","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1164\/rccm.200508-1321OC","volume":"173","author":"NC Barnes","year":"2006","unstructured":"Barnes NC, Qiu YS, Pavord ID, Parker D, Davis PA, Zhu J, Johnson M, Thomson NC, Jeffery PK (2006) Antiinflammatory effects of salmeterol\/fluticasone propionate in chronic obstructive lung disease. Am J Respir Crit Care Med 173:736\u2013743","journal-title":"Am J Respir Crit Care Med"},{"key":"682_CR68","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1164\/rccm.200709-1356OC","volume":"177","author":"DD Sin","year":"2008","unstructured":"Sin DD, Man SF, Marciniuk DD, Ford G, Fitzgerald M, Wong E, York E, Mainra RR, Ramesh W, Melenka LS et al (2008) The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 177:1207\u20131214","journal-title":"Am J Respir Crit Care Med"},{"key":"682_CR69","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1513\/pats.200406-034MS","volume":"2","author":"SF Man","year":"2005","unstructured":"Man SF, Sin DD (2005) Effects of corticosteroids on systemic inflammation in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2:78\u201382","journal-title":"Proc Am Thorac Soc"},{"key":"682_CR70","doi-asserted-by":"crossref","first-page":"S261","DOI":"10.1067\/mai.2002.129705","volume":"110","author":"IM Adcock","year":"2002","unstructured":"Adcock IM, Maneechotesuwan K, Usmani O (2002) Molecular interactions between glucocorticoids and long-acting beta2-agonists. J Allergy Clin Immunol 110:S261\u2013S268","journal-title":"J Allergy Clin Immunol"},{"key":"682_CR71","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1164\/rccm.200408-1041OC","volume":"172","author":"OS Usmani","year":"2005","unstructured":"Usmani OS, Ito K, Maneechotesuwan K, Ito M, Johnson M, Barnes PJ, Adcock IM (2005) Glucocorticoid receptor nuclear translocation in airway cells after inhaled combination therapy. Am J Respir Crit Care Med 172:704\u2013712","journal-title":"Am J Respir Crit Care Med"},{"key":"682_CR72","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(02)11319-5","volume":"360","author":"M Roth","year":"2002","unstructured":"Roth M, Johnson PR, Rudiger JJ, King GG, Ge Q, Burgess JK, Anderson G, Tamm M, Black JL (2002) Interaction between glucocorticoids and beta2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling. Lancet 360:1293\u20131299","journal-title":"Lancet"},{"key":"682_CR73","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2165\/00151829-200403050-00002","volume":"3","author":"KF Chung","year":"2004","unstructured":"Chung KF, Adcock IM (2004) Combination therapy of long-acting beta2-adrenoceptor agonists and corticosteroids for asthma. Treat Respir Med 3:279\u2013289","journal-title":"Treat Respir Med"},{"key":"682_CR74","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejphar.2005.12.049","volume":"533","author":"DD Sin","year":"2006","unstructured":"Sin DD, Man SF (2006) Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases. Eur J Pharmacol 533:28\u201335","journal-title":"Eur J Pharmacol"},{"key":"682_CR75","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jaci.2006.11.639","volume":"119","author":"WC Moore","year":"2007","unstructured":"Moore WC, Bleecker ER, Curran-Everett D, Erzurum SC, Ameredes BT, Bacharier L, Calhoun WJ, Castro M, Chung KF, Clark MP et al (2007) Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute\u2019s Severe Asthma Research Program. J Allergy Clin Immunol 119:405\u2013413","journal-title":"J Allergy Clin Immunol"},{"key":"682_CR76","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1183\/09031936.04.00077803","volume":"24","author":"D Bumbacea","year":"2004","unstructured":"Bumbacea D, Campbell D, Nguyen L, Carr D, Barnes PJ, Robinson D, Chung KF (2004) Parameters associated with persistent airflow obstruction in chronic severe asthma. Eur Respir J 24:122\u2013128","journal-title":"Eur Respir J"},{"key":"682_CR77","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1183\/09031936.03.00017003","volume":"22","author":"DS Robinson","year":"2003","unstructured":"Robinson DS, Campbell DA, Durham SR, Pfeffer J, Barnes PJ, Chung KF (2003) Systematic assessment of difficult-to-treat asthma. Eur Respir J 22:478\u2013483","journal-title":"Eur Respir J"},{"key":"682_CR78","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1164\/ajrccm.160.5.9806170","volume":"160","author":"A Jatakanon","year":"1999","unstructured":"Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, Barnes PJ (1999) Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 160:1532\u20131539","journal-title":"Am J Respir Crit Care Med"},{"key":"682_CR79","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1164\/ajrccm.160.3.9812110","volume":"160","author":"SE Wenzel","year":"1999","unstructured":"Wenzel SE, Schwartz LB, Langmack EL, Halliday JL, Trudeau JB, Gibbs RL, Chu HW (1999) Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 160:1001\u20131008","journal-title":"Am J Respir Crit Care Med"},{"key":"682_CR80","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1164\/rccm.200209-1030OC","volume":"167","author":"L Benayoun","year":"2003","unstructured":"Benayoun L, Druilhe A, Dombret MC, Aubier M, Pretolani M (2003) Airway structural alterations selectively associated with severe asthma. Am J Respir Crit Care Med 167:1360\u20131368","journal-title":"Am J Respir Crit Care Med"},{"key":"682_CR81","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.jaci.2007.01.055","volume":"119","author":"A Bourdin","year":"2007","unstructured":"Bourdin A, Neveu D, Vachier I, Paganin F, Godard P, Chanez P (2007) Specificity of basement membrane thickening in severe asthma. J Allergy Clin Immunol 119:1367\u20131374","journal-title":"J Allergy Clin Immunol"},{"key":"682_CR82","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1164\/rccm.200607-1062OC","volume":"176","author":"L Cohen","year":"2007","unstructured":"Cohen L, Xueping E, Tarsi J, Ramkumar T, Horiuchi TK, Cochran R, DeMartino S, Schechtman KB, Hussain I, Holtzman MJ et al (2007) Epithelial cell proliferation contributes to airway remodeling in severe asthma. Am J Respir Crit Care Med 176:138\u2013145","journal-title":"Am J Respir Crit Care Med"},{"key":"682_CR83","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1164\/rccm.200512-1930OC","volume":"174","author":"M Hew","year":"2006","unstructured":"Hew M, Bhavsar P, Torrego A, Meah S, Khorasani N, Barnes PJ, Adcock I, Fan CK (2006) Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma. Am J Respir Crit Care Med 174:134\u2013141","journal-title":"Am J Respir Crit Care Med"},{"key":"682_CR84","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1164\/rccm.200204-298OC","volume":"167","author":"SV Culpitt","year":"2003","unstructured":"Culpitt SV, Rogers DF, Shah P, De Matos C, Russell REK, Donnelly LE, Barnes PJ (2003) Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 167:24\u201331","journal-title":"Am J Respir Crit Care Med"},{"key":"682_CR85","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1056\/NEJMoa041892","volume":"352","author":"K Ito","year":"2005","unstructured":"Ito K, Ito M, Elliott WM, Cosio B, Caramori G, Kon OM, Barczyk A, Hayashi S, Adcock IM, Hogg JC et al (2005) Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med 352:1967\u20131976","journal-title":"N Engl J Med"},{"key":"682_CR86","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/sj.emboj.7601516","volume":"26","author":"C Marban","year":"2007","unstructured":"Marban C, Suzanne S, Dequiedt F, de Walque S, Redel L, Van Lint C, Aunis D, Rohr O (2007) Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing. EMBO J 26:412\u2013423","journal-title":"EMBO J"},{"key":"682_CR87","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1164\/rccm.200505-725OC","volume":"174","author":"P Szulakowski","year":"2006","unstructured":"Szulakowski P, Crowther AJ, Jimenez LA, Donaldson K, Mayer R, Leonard TB, MacNee W, Drost EM (2006) The effect of smoking on the transcriptional regulation of lung inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 174:41\u201350","journal-title":"Am J Respir Crit Care Med"},{"key":"682_CR88","doi-asserted-by":"crossref","first-page":"8921","DOI":"10.1073\/pnas.132556899","volume":"99","author":"K Ito","year":"2002","unstructured":"Ito K, Lim S, Caramori G, Cosio B, Chung KF, Adcock IM, Barnes PJ (2002) A molecular mechanism of action of theophylline: induction of histone deacetylase activity to decrease inflammatory gene expression. Proc Natl Acad Sci USA 99:8921\u20138926","journal-title":"Proc Natl Acad Sci USA"},{"key":"682_CR89","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1084\/jem.20050466","volume":"203","author":"K Ito","year":"2006","unstructured":"Ito K, Yamamura S, Essilfie-Quaye S, Cosio B, Ito M, Barnes PJ, Adcock IM (2006) Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression. J Exp Med 203:7\u201313","journal-title":"J Exp Med"},{"key":"682_CR90","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1084\/jem.181.1.33","volume":"181","author":"DY Leung","year":"1995","unstructured":"Leung DY, Martin RJ, Szefler SJ, Sher ER, Ying S, Kay AB, Hamid Q (1995) Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma. J Exp Med 181:33\u201340","journal-title":"J Exp Med"},{"key":"682_CR91","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1067\/mai.2002.122465","volume":"109","author":"E Irusen","year":"2002","unstructured":"Irusen E, Matthews JG, Takahashi A, Barnes PJ, Chung KF, Adcock IM (2002) p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma. J Allergy Clin Immunol 109:649\u2013657","journal-title":"J Allergy Clin Immunol"},{"key":"682_CR92","doi-asserted-by":"crossref","first-page":"6865","DOI":"10.1073\/pnas.121455098","volume":"98","author":"JC Webster","year":"2001","unstructured":"Webster JC, Oakley RH, Jewell CM, Cidlowski JA (2001) Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative beta isoform: a mechanism for the generation of glucocorticoid resistance. Proc Natl Acad Sci USA 98:6865\u20136870","journal-title":"Proc Natl Acad Sci USA"},{"key":"682_CR93","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1164\/rccm.200507-1046OC","volume":"173","author":"E Goleva","year":"2006","unstructured":"Goleva E, Li LB, Eves PT, Strand MJ, Martin RJ, Leung DY (2006) Increased glucocorticoid receptor beta alters steroid response in glucocorticoid-insensitive asthma. Am J Respir Crit Care Med 173:607\u2013616","journal-title":"Am J Respir Crit Care Med"},{"key":"682_CR94","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1172\/JCI2680","volume":"102","author":"SJ Lane","year":"1998","unstructured":"Lane SJ, Adcock IM, Richards D, Hawrylowicz C, Barnes PJ, Lee TH (1998) Corticosteroid-resistant bronchial asthma is associated with increased c-fos expression in monocytes and T lymphocytes. J Clin Invest 102:2156\u20132164","journal-title":"J Clin Invest"},{"key":"682_CR95","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0140-6736(04)15650-X","volume":"363","author":"PJ Barnes","year":"2004","unstructured":"Barnes PJ, Ito K, Adcock IM (2004) Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase. Lancet 363:731\u2013733","journal-title":"Lancet"},{"key":"682_CR96","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1084\/jem.20050466","volume":"203","author":"K Ito","year":"2006","unstructured":"Ito K, Yamamura S, Essilfie-Quaye S, Cosio B, Ito M, Barnes PJ, Adcock IM (2006) Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression. J Exp Med 203:7\u201313","journal-title":"J Exp Med"},{"key":"682_CR97","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1084\/jem.20052211","volume":"202","author":"CM Hawrylowicz","year":"2005","unstructured":"Hawrylowicz CM (2005) Regulatory T cells and IL-10 in allergic inflammation. J Exp Med 202:1459\u20131463","journal-title":"J Exp Med"},{"key":"682_CR98","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1513\/pats.200409-048TA","volume":"1","author":"K Biggadike","year":"2004","unstructured":"Biggadike K, Uings I, Farrow SN (2004) Designing corticosteroid drugs for pulmonary selectivity. Proc Am Thorac Soc 1:352\u2013355","journal-title":"Proc Am Thorac Soc"},{"key":"682_CR99","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0091-6749(96)80217-X","volume":"97","author":"M Johnson","year":"1996","unstructured":"Johnson M (1996) Pharmacodynamics and pharmacokinetics of inhaled glucocorticoids. J Allergy Clin Immunol 97:169\u2013176","journal-title":"J Allergy Clin Immunol"},{"key":"682_CR100","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1513\/pats.200403-025MS","volume":"1","author":"J Winkler","year":"2004","unstructured":"Winkler J, Hochhaus G, Derendorf H (2004) How the lung handles drugs: pharmacokinetics and pharmacodynamics of inhaled corticosteroids. Proc Am Thorac Soc 1:356\u2013363","journal-title":"Proc Am Thorac Soc"},{"key":"682_CR101","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1465-9921-8-54","volume":"8","author":"A Valotis","year":"2007","unstructured":"Valotis A, Hogger P (2007) Human receptor kinetics and lung tissue retention of the enhanced-affinity glucocorticoid fluticasone furoate. Respir Res 8:54","journal-title":"Respir Res"},{"key":"682_CR102","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/thorax.56.3.186","volume":"56","author":"TW Harrison","year":"2001","unstructured":"Harrison TW, Wisniewski A, Honour J, Tattersfield AE (2001) Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects. Thorax 56:186\u2013191","journal-title":"Thorax"},{"key":"682_CR103","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1136\/thorax.58.3.258","volume":"58","author":"TW Harrison","year":"2003","unstructured":"Harrison TW, Tattersfield AE (2003) Plasma concentrations of fluticasone propionate and budesonide following inhalation from dry powder inhalers by healthy and asthmatic subjects. Thorax 58:258\u2013260","journal-title":"Thorax"},{"key":"682_CR104","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2165\/00063030-200115060-00006","volume":"15","author":"TW Harrison","year":"2001","unstructured":"Harrison TW (2001) Systemic availability of inhaled budesonide and fluticasone propionate: healthy versus asthmatic lungs. BioDrugs 15:405\u2013411","journal-title":"BioDrugs"},{"key":"682_CR105","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.rmed.2006.04.015","volume":"100","author":"NP Adams","year":"2006","unstructured":"Adams NP, Jones PW (2006) The dose-response characteristics of inhaled corticosteroids when used to treat asthma: an overview of Cochrane systematic reviews. Respir Med 100:1297\u20131306","journal-title":"Respir Med"},{"key":"682_CR106","doi-asserted-by":"crossref","unstructured":"Adams NP, Bestall JC, Jones P, Lasserson TJ, Griffiths B, Cates CJ (2008) Fluticasone at different doses for chronic asthma in adults and children. Cochrane Database Syst Rev CD003534","DOI":"10.1002\/14651858.CD003534.pub3"},{"key":"682_CR107","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1164\/rccm.2112055","volume":"166","author":"DA Mahler","year":"2002","unstructured":"Mahler DA, Wire P, Horstman D, Chang CN, Yates J, Fischer T, Shah T (2002) Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 166:1084\u20131091","journal-title":"Am J Respir Crit Care Med"},{"key":"682_CR108","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1378\/chest.124.3.834","volume":"124","author":"NA Hanania","year":"2003","unstructured":"Hanania NA, Darken P, Horstman D, Reisner C, Lee B, Davis S, Shah T (2003) The efficacy and safety of fluticasone propionate (250 microg)\/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD. Chest 124:834\u2013843","journal-title":"Chest"},{"key":"682_CR109","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0140-6736(03)12459-2","volume":"361","author":"P Calverley","year":"2003","unstructured":"Calverley P, Pauwels R, Vestbo J, Jones P, Pride N, Gulsvik A, Anderson J, Maden C (2003) Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 361:449\u2013456","journal-title":"Lancet"},{"key":"682_CR110","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1164\/ajrccm\/140.1.167","volume":"140","author":"S Salmeron","year":"1989","unstructured":"Salmeron S, Guerin JC, Godard P, Renon D, Henry-Amar M, Duroux P, Taytard A (1989) High doses of inhaled corticosteroids in unstable chronic asthma. A multicenter, double-blind, placebo-controlled study. Am Rev Respir Dis 140:167\u2013171","journal-title":"Am Rev Respir Dis"},{"key":"682_CR111","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1056\/NEJM199108083250603","volume":"325","author":"T Haahtela","year":"1991","unstructured":"Haahtela T, Jarvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, Nikander K, Persson T, Reinikainen K, Selroos O et al (1991) Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma [see comments]. N Engl J Med 325:388\u2013392","journal-title":"N Engl J Med"},{"key":"682_CR112","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0140-6736(03)12891-7","volume":"361","author":"RA Pauwels","year":"2003","unstructured":"Pauwels RA, Pedersen S, Busse WW, Tan WC, Chen YZ, Ohlsson SV, Ullman A, Lamm CJ, O\u2019Byrne PM (2003) Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet 361:1071\u20131076","journal-title":"Lancet"},{"key":"682_CR113","doi-asserted-by":"crossref","unstructured":"(2000) Long-term effects of budesonide or nedocromil in children with asthma. The Childhood Asthma Management Program Research Group. N Engl J Med 343:1054\u20131063","DOI":"10.1056\/NEJM200010123431501"},{"key":"682_CR114","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1164\/ajrccm.164.8.2104102","volume":"164","author":"PM O\u2019Byrne","year":"2001","unstructured":"O\u2019Byrne PM, Barnes PJ, Rodriguez-Roisin R, Runnerstrom E, Sandstrom T, Svensson K, Tattersfield A (2001) Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. Am J Respir Crit Care Med 164:1392\u20131397","journal-title":"Am J Respir Crit Care Med"},{"key":"682_CR115","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1067\/mai.2002.129413","volume":"110","author":"E Israel","year":"2002","unstructured":"Israel E, Chervinsky PS, Friedman B, van Bavel J, Skalky CS, Ghannam AF, Bird SR, Edelman JM (2002) Effects of montelukast and beclomethasone on airway function and asthma control. J Allergy Clin Immunol 110:847\u2013854","journal-title":"J Allergy Clin Immunol"},{"key":"682_CR116","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1183\/09031936.03.00028803","volume":"21","author":"RA Baumgartner","year":"2003","unstructured":"Baumgartner RA, Martinez G, Edelman JM, Rodriguez Gomez GG, Bernstein M, Bird S, Angner R, Polis A, Dass SB, Lu S et al (2003) Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone. Eur Respir J 21:123\u2013128","journal-title":"Eur Respir J"},{"key":"682_CR117","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1056\/NEJMoa063861","volume":"356","author":"A Papi","year":"2007","unstructured":"Papi A, Canonica GW, Maestrelli P, Paggiaro P, Olivieri D, Pozzi E, Crimi N, Vignola AM, Morelli P, Nicolini G et al (2007) Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma. N Engl J Med 356:2040\u20132052","journal-title":"N Engl J Med"},{"key":"682_CR118","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1056\/NEJMoa042552","volume":"352","author":"HA Boushey","year":"2005","unstructured":"Boushey HA, Sorkness CA, King TS, Sullivan SD, Fahy JV, Lazarus SC, Chinchilli VM, Craig TJ, Dimango EA, Deykin A et al (2005) Daily versus as-needed corticosteroids for mild persistent asthma. N Engl J Med 352:1519\u20131528","journal-title":"N Engl J Med"},{"key":"682_CR119","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jaci.2006.10.035","volume":"119","author":"RJ Martin","year":"2007","unstructured":"Martin RJ, Szefler SJ, King TS, Kraft M, Boushey HA, Chinchilli VM, Craig TJ, Dimango EA, Deykin A, Fahy JV et al (2007) The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial. J Allergy Clin Immunol 119:73\u201380","journal-title":"J Allergy Clin Immunol"},{"key":"682_CR120","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1164\/rccm.200511-1746OC","volume":"175","author":"SC Lazarus","year":"2007","unstructured":"Lazarus SC, Chinchilli VM, Rollings NJ, Boushey HA, Cherniack R, Craig TJ, Deykin A, DiMango E, Fish JE, Ford JG et al (2007) Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med 175:783\u2013790","journal-title":"Am J Respir Crit Care Med"},{"key":"682_CR121","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/thorax.57.3.226","volume":"57","author":"GW Chalmers","year":"2002","unstructured":"Chalmers GW, MacLeod KJ, Little SA, Thomson LJ, McSharry CP, Thomson NC (2002) Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax 57:226\u2013230","journal-title":"Thorax"},{"key":"682_CR122","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jaci.2006.10.018","volume":"119","author":"M Duong","year":"2007","unstructured":"Duong M, Gauvreau G, Watson R, Obminski G, Strinich T, Evans M, Howie K, Killian K, O\u2019Byrne PM (2007) The effects of inhaled budesonide and formoterol in combination and alone when given directly after allergen challenge. J Allergy Clin Immunol 119:322\u2013327","journal-title":"J Allergy Clin Immunol"},{"key":"682_CR123","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1001\/jama.292.3.367","volume":"292","author":"DD Sin","year":"2004","unstructured":"Sin DD, Man J, Sharpe H, Gan WQ, Man SF (2004) Pharmacological management to reduce exacerbations in adults with asthma: a systematic review and meta-analysis. JAMA 292:367\u2013376","journal-title":"JAMA"},{"key":"682_CR124","doi-asserted-by":"crossref","unstructured":"Greenstone IR, Ni Chroinin MN, Masse V, Danish A, Magdalinos H, Zhang X, Ducharme FM (2005) Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma. Cochrane Database Syst Rev CD005533","DOI":"10.1002\/14651858.CD005533"},{"key":"682_CR125","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1164\/rccm.200407-884OC","volume":"171","author":"PM O\u2019Byrne","year":"2005","unstructured":"O\u2019Byrne PM, Bisgaard H, Godard PP, Pistolesi M, Palmqvist M, Zhu Y, Ekstrom T, Bateman ED (2005) Budesonide\/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med 171:129\u2013136","journal-title":"Am J Respir Crit Care Med"},{"key":"682_CR126","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1164\/ajrccm.153.5.8630590","volume":"153","author":"A Woolcock","year":"1996","unstructured":"Woolcock A, Lundback B, Ringdal N, Jacques LA (1996) Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 153:1481\u20131488","journal-title":"Am J Respir Crit Care Med"},{"key":"682_CR127","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1183\/09031936.01.00065801","volume":"18","author":"O Zetterstrom","year":"2001","unstructured":"Zetterstrom O, Buhl R, Mellem H, Perpina M, Hedman J, O\u2019Neill S, Ekstrom T (2001) Improved asthma control with budesonide\/formoterol in a single inhaler, compared with budesonide alone. Eur Respir J 18:262\u2013268","journal-title":"Eur Respir J"},{"key":"682_CR128","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1164\/rccm.200401-033OC","volume":"170","author":"ED Bateman","year":"2004","unstructured":"Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA, Pedersen SE (2004) Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med 170:836\u2013844","journal-title":"Am J Respir Crit Care Med"},{"key":"682_CR129","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJM199711133372001","volume":"337","author":"RA Pauwels","year":"1997","unstructured":"Pauwels RA, Lofdahl C, Postma D, Tattersfield A, O\u2019Byrne P, Barnes PJ, Ullman A (1997) Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med 337:1405\u20131411","journal-title":"N Engl J Med"},{"key":"682_CR130","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1378\/chest.128.3.1121","volume":"128","author":"SE Overbeek","year":"2005","unstructured":"Overbeek SE, Mulder PG, Baelemans SM, Hoogsteden HC, Prins JB (2005) Formoterol added to low-dose budesonide has no additional antiinflammatory effect in asthmatic patients. Chest 128:1121\u20131127","journal-title":"Chest"},{"key":"682_CR131","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1136\/thx.2005.051292","volume":"61","author":"JG Koopmans","year":"2006","unstructured":"Koopmans JG, Lutter R, Jansen HM, van der Zee JS (2006) Adding salmeterol to an inhaled corticosteroid: long term effects on bronchial inflammation in asthma. Thorax 61:306\u2013312","journal-title":"Thorax"},{"key":"682_CR132","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jaci.2005.08.016","volume":"116","author":"JG Koopmans","year":"2005","unstructured":"Koopmans JG, Lutter R, Jansen HM, van der Zee JS (2005) Adding salmeterol to an inhaled corticosteroid reduces allergen-induced serum IL-5 and peripheral blood eosinophils. J Allergy Clin Immunol 116:1007\u20131013","journal-title":"J Allergy Clin Immunol"},{"key":"682_CR133","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0140-6736(06)69284-2","volume":"368","author":"KF Rabe","year":"2006","unstructured":"Rabe KF, Atienza T, Magyar P, Larsson P, Jorup C, Lalloo UG (2006) Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. Lancet 368:744\u2013753","journal-title":"Lancet"},{"key":"682_CR134","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jaci.2005.11.036","volume":"117","author":"ED Bateman","year":"2006","unstructured":"Bateman ED, Jacques L, Goldfrad C, Atienza T, Mihaescu T, Duggan M (2006) Asthma control can be maintained when fluticasone propionate\/salmeterol in a single inhaler is stepped down. J Allergy Clin Immunol 117:563\u2013570","journal-title":"J Allergy Clin Immunol"},{"key":"682_CR135","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1465-9921-7-110","volume":"7","author":"J Lotvall","year":"2006","unstructured":"Lotvall J, Langley S, Woodcock A (2006) Inhaled steroid\/long-acting beta 2 agonist combination products provide 24 hours improvement in lung function in adult asthmatic patients. Respir Res 7:110","journal-title":"Respir Res"},{"key":"682_CR136","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ijpharm.2006.02.040","volume":"316","author":"WY Tarsin","year":"2006","unstructured":"Tarsin WY, Pearson SB, Assi KH, Chrystyn H (2006) Emitted dose estimates from Seretide Diskus and Symbicort Turbuhaler following inhalation by severe asthmatics. Int J Pharm 316:131\u2013137","journal-title":"Int J Pharm"},{"key":"682_CR137","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1183\/09031936.05.00028305","volume":"26","author":"C Vogelmeier","year":"2005","unstructured":"Vogelmeier C, D\u2019Urzo A, Pauwels R, Merino JM, Jaspal M, Boutet S, Naya I, Price D (2005) Budesonide\/formoterol maintenance and reliever therapy: an effective asthma treatment option? Eur Respir J 26:819\u2013828","journal-title":"Eur Respir J"},{"key":"682_CR138","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.clinthera.2005.03.006","volume":"27","author":"JM Fitzgerald","year":"2005","unstructured":"Fitzgerald JM, Boulet LP, Follows RM (2005) The CONCEPT trial: a 1-year, multicenter, randomized, double-blind, double-dummy comparison of a stable dosing regimen of salmeterol\/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol\/budesonide in adults with persistent asthma. Clin Ther 27:393\u2013406","journal-title":"Clin Ther"},{"key":"682_CR139","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1183\/09031936.00095906","volume":"29","author":"A Papi","year":"2007","unstructured":"Papi A, Paggiaro PL, Nicolini G, Vignola AM, Fabbri LM (2007) Beclomethasone\/formoterol versus budesonide\/formoterol combination therapy in asthma. Eur Respir J 29:682\u2013689","journal-title":"Eur Respir J"},{"key":"682_CR140","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1016\/j.rmed.2007.07.014","volume":"101","author":"J Bousquet","year":"2007","unstructured":"Bousquet J, Boulet LP, Peters MJ, Magnussen H, Quiralte J, Martinez-Aguilar NE, Carlsheimer A (2007) Budesonide\/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol\/fluticasone. Respir Med 101:2437\u20132446","journal-title":"Respir Med"},{"key":"682_CR141","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.rmed.2008.09.002","volume":"103","author":"G Huchon","year":"2009","unstructured":"Huchon G, Magnussen H, Chuchalin A, Dymek L, Gonod FB, Bousquet J (2009) Lung function and asthma control with beclomethasone and formoterol in a single inhaler. Respir Med 103:41\u201349","journal-title":"Respir Med"},{"key":"682_CR142","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1136\/bmj.320.7245.1297","volume":"320","author":"PS Burge","year":"2000","unstructured":"Burge PS, Calverley PM, Jones PW, Spencer S, Anderson JA, Maslen TK (2000) Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. Br Med J 320:1297\u20131303","journal-title":"Br Med J"},{"key":"682_CR143","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1056\/NEJMoa002304","volume":"345","author":"E Israel","year":"2001","unstructured":"Israel E, Banerjee TR, Fitzmaurice GM, Kotlov TV, LaHive K, LeBoff MS (2001) Effects of inhaled glucocorticoids on bone density in premenopausal women. N Engl J Med 345:941\u2013947","journal-title":"N Engl J Med"},{"key":"682_CR144","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1164\/ajrccm.163.5.2101039","volume":"163","author":"RA Pauwels","year":"2001","unstructured":"Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS (2001) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI\/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 163:1256\u20131276","journal-title":"Am J Respir Crit Care Med"},{"key":"682_CR145","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1164\/ajrccm.160.5.9811058","volume":"160","author":"SV Culpitt","year":"1999","unstructured":"Culpitt SV, Maziak W, Loukidis S, Nightingale JA, Matthews JL, Barnes PJ (1999) Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160:1635\u20131639","journal-title":"Am J Respir Crit Care Med"},{"key":"682_CR146","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1164\/ajrccm.155.2.9032192","volume":"155","author":"VM Keatings","year":"1997","unstructured":"Keatings VM, Jatakanon A, Worsdell YM, Barnes PJ (1997) Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med 155:542\u2013548","journal-title":"Am J Respir Crit Care Med"},{"key":"682_CR147","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(98)10019-3","volume":"353","author":"J Vestbo","year":"1999","unstructured":"Vestbo J, Sorensen T, Lange P, Brix A, Torre P, Viskum K (1999) Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 353:1819\u20131823","journal-title":"Lancet"},{"key":"682_CR148","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1056\/NEJM199906243402503","volume":"340","author":"RA Pauwels","year":"1999","unstructured":"Pauwels RA, Lofdahl CG, Laitinen LA, Schouten JP, Postma DS, Pride NB, Ohlsson SV (1999) Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N Engl J Med 340:1948\u20131953","journal-title":"N Engl J Med"},{"key":"682_CR149","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1056\/NEJM200012283432601","volume":"343","author":"Lung Health Study Research Group","year":"2000","unstructured":"Lung Health Study Research Group (2000) Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N Engl J Med 343:1902\u20131909","journal-title":"N Engl J Med"},{"key":"682_CR150","doi-asserted-by":"crossref","first-page":"864","DOI":"10.7326\/0003-4819-139-10-200311180-00019","volume":"139","author":"ER Sutherland","year":"2003","unstructured":"Sutherland ER (2003) Inhaled corticosteroids in chronic obstructive pulmonary disease. Ann Intern Med 139:864\u2013865","journal-title":"Ann Intern Med"},{"key":"682_CR151","doi-asserted-by":"crossref","first-page":"969","DOI":"10.7326\/0003-4819-138-12-200306170-00008","volume":"138","author":"KB Highland","year":"2003","unstructured":"Highland KB, Strange C, Heffner JE (2003) Long-term effects of inhaled corticosteroids on FEV1 in patients with chronic obstructive pulmonary disease. A meta-analysis. Ann Intern Med 138:969\u2013973","journal-title":"Ann Intern Med"},{"key":"682_CR152","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1164\/rccm.200712-1869OC","volume":"178","author":"BR Celli","year":"2008","unstructured":"Celli BR, Thomas NE, Anderson JA, Ferguson GT, Jenkins CR, Jones PW, Vestbo J, Knobil K, Yates JC, Calverley PM (2008) Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med 178:332\u2013338","journal-title":"Am J Respir Crit Care Med"},{"key":"682_CR153","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1183\/09031936.03.00031402","volume":"21","author":"W Szafranski","year":"2003","unstructured":"Szafranski W, Cukier A, Ramirez A, Menga G, Sansores R, Nahabedian S, Peterson S, Olsson H (2003) Efficacy and safety of budesonide\/formoterol in the management of chronic obstructive pulmonary disease. Eur Respir J 21:74\u201381","journal-title":"Eur Respir J"},{"key":"682_CR154","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJMoa063070","volume":"356","author":"PM Calverley","year":"2007","unstructured":"Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J (2007) Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 356:775\u2013789","journal-title":"N Engl J Med"},{"key":"682_CR155","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1164\/rccm.200206-512OC","volume":"166","author":"P Valk van der","year":"2002","unstructured":"van der Valk P, Monninkhof E, van der Palen J, Zielhuis G, van Herwaarden C (2002) Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE study. Am J Respir Crit Care Med 166:1358\u20131363","journal-title":"Am J Respir Crit Care Med"},{"key":"682_CR156","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0140-6736(97)03471-5","volume":"351","author":"PL Paggiaro","year":"1998","unstructured":"Paggiaro PL, Dahle R, Bakran I, Frith L, Hollingworth K, Efthimiou J (1998) Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group. Lancet 351:773\u2013780","journal-title":"Lancet"},{"key":"682_CR157","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1465-9921-9-73","volume":"9","author":"PM Calverley","year":"2008","unstructured":"Calverley PM, Rennard S, Nelson HS, Karpel JP, Abbate EH, Stryszak P, Staudinger H (2008) One-year treatment with mometasone furoate in chronic obstructive pulmonary disease. Respir Res 9:73","journal-title":"Respir Res"},{"key":"682_CR158","doi-asserted-by":"crossref","first-page":"639","DOI":"10.7326\/0003-4819-147-9-200711060-00009","volume":"147","author":"TJ Wilt","year":"2007","unstructured":"Wilt TJ, Niewoehner D, MacDonald R, Kane RL (2007) Management of stable chronic obstructive pulmonary disease: a systematic review for a clinical practice guideline. Ann Intern Med 147:639\u2013653","journal-title":"Ann Intern Med"},{"key":"682_CR159","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1164\/rccm.200610-1563OC","volume":"176","author":"PM Calverley","year":"2007","unstructured":"Calverley PM, Sanchez-Toril F, McIvor A, Teichmann P, Bredenbroeker D, Fabbri LM (2007) Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 176:154\u2013161","journal-title":"Am J Respir Crit Care Med"},{"key":"682_CR160","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1001\/jama.290.17.2301","volume":"290","author":"DD Sin","year":"2003","unstructured":"Sin DD, McAlister FA, Man SF, Anthonisen NR (2003) Contemporary management of chronic obstructive pulmonary disease: scientific review. JAMA 290:2301\u20132312","journal-title":"JAMA"},{"key":"682_CR161","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1164\/rccm.200206-512OC","volume":"166","author":"P Valk van der","year":"2002","unstructured":"van der Valk P, Monninkhof E, van der Palen J, Zielhuis G, van Herwaarden C (2002) Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE study. Am J Respir Crit Care Med 166:1358\u20131363","journal-title":"Am J Respir Crit Care Med"},{"key":"682_CR162","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1183\/09031936.03.00013303","volume":"21","author":"PW Jones","year":"2003","unstructured":"Jones PW, Willits LR, Burge PS, Calverley PM (2003) Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations. Eur Respir J 21:68\u201373","journal-title":"Eur Respir J"},{"key":"682_CR163","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/thx.2004.034280","volume":"60","author":"EF Wouters","year":"2005","unstructured":"Wouters EF, Postma DS, Fokkens B, Hop WC, Prins J, Kuipers AF, Pasma HR, Hensing CA, Creutzberg EC (2005) Withdrawal of fluticasone propionate from combined salmeterol\/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial. Thorax 60:480\u2013487","journal-title":"Thorax"},{"key":"682_CR164","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1164\/ajrccm.164.3.2002052","volume":"164","author":"A O\u2019Brien","year":"2001","unstructured":"O\u2019Brien A, Russo-Magno P, Karki A, Hiranniramol S, Hardin M, Kaszuba M, Sherman C, Rounds S (2001) Effects of withdrawal of inhaled steroids in men with severe irreversible airflow obstruction. Am J Respir Crit Care Med 164:365\u2013371","journal-title":"Am J Respir Crit Care Med"},{"key":"682_CR165","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1164\/ajrccm.164.4.2009033","volume":"164","author":"DD Sin","year":"2001","unstructured":"Sin DD, Tu JV (2001) Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164:580\u2013584","journal-title":"Am J Respir Crit Care Med"},{"key":"682_CR166","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF03256640","volume":"2","author":"JB Soriano","year":"2003","unstructured":"Soriano JB, Kiri VA, Pride NB, Vestbo J (2003) Inhaled corticosteroids with\/without long-acting beta-agonists reduce the risk of rehospitalization and death in COPD patients. Am J Respir Med 2:67\u201374","journal-title":"Am J Respir Med"},{"key":"682_CR167","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1183\/09031936.02.00301302","volume":"20","author":"JB Soriano","year":"2002","unstructured":"Soriano JB, Vestbo J, Pride NB, Kiri V, Maden C, Maier WC (2002) Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice. Eur Respir J 20:819\u2013825","journal-title":"Eur Respir J"},{"key":"682_CR168","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1183\/09031936.04.00062504","volume":"23","author":"S Suissa","year":"2004","unstructured":"Suissa S (2004) Inhaled steroids and mortality in COPD: bias from unaccounted immortal time. Eur Respir J 23:391\u2013395","journal-title":"Eur Respir J"},{"key":"682_CR169","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1139\/y06-093","volume":"85","author":"DD Sin","year":"2007","unstructured":"Sin DD, Man SF (2007) Systemic inflammation and mortality in chronic obstructive pulmonary disease. Can J Physiol Pharmacol 85:141\u2013147","journal-title":"Can J Physiol Pharmacol"},{"key":"682_CR170","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1183\/09031936.03.00027003","volume":"22","author":"PM Calverley","year":"2003","unstructured":"Calverley PM, Boonsawat W, Cseke Z, Zhong N, Peterson S, Olsson H (2003) Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease. Eur Respir J 22:912\u2013919","journal-title":"Eur Respir J"},{"key":"682_CR171","first-page":"445","volume":"1","author":"PW Jones","year":"1991","unstructured":"Jones PW (1991) Measurement of quality of life in chronic obstructive lung disease. Eur Resp Rev 1:445\u2013453","journal-title":"Eur Resp Rev"},{"key":"682_CR172","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1136\/thx.2003.014936","volume":"59","author":"JM Fitzgerald","year":"2004","unstructured":"Fitzgerald JM, Becker A, Sears MR, Mink S, Chung K, Lee J (2004) Doubling the dose of budesonide versus maintenance treatment in asthma exacerbations. Thorax 59:550\u2013556","journal-title":"Thorax"},{"key":"682_CR173","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0140-6736(03)15384-6","volume":"363","author":"TW Harrison","year":"2004","unstructured":"Harrison TW, Oborne J, Newton S, Tattersfield AE (2004) Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial. Lancet 363:271\u2013275","journal-title":"Lancet"},{"key":"682_CR174","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1445-5994.2005.00972.x","volume":"35","author":"G Rice-McDonald","year":"2005","unstructured":"Rice-McDonald G, Bowler S, Staines G, Mitchell C (2005) Doubling daily inhaled corticosteroid dose is ineffective in mild to moderately severe attacks of asthma in adults. Intern Med J 35:693\u2013698","journal-title":"Intern Med J"},{"key":"682_CR175","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1164\/ajrccm.163.1.9807061","volume":"163","author":"PG Gibson","year":"2001","unstructured":"Gibson PG, Saltos N, Fakes K (2001) Acute anti-inflammatory effects of inhaled budesonide in asthma: a randomized controlled trial. Am J Respir Crit Care Med 163:32\u201336","journal-title":"Am J Respir Crit Care Med"},{"key":"682_CR176","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1164\/ajrccm.157.3.9704022","volume":"157","author":"G Rodrigo","year":"1998","unstructured":"Rodrigo G, Rodrigo C (1998) Inhaled flunisolide for acute severe asthma. Am J Respir Crit Care Med 157:698\u2013703","journal-title":"Am J Respir Crit Care Med"},{"key":"682_CR177","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1378\/chest.118.6.1547","volume":"118","author":"GJ Rodrigo","year":"2000","unstructured":"Rodrigo GJ, Rodrigo C (2000) Rapid-onset asthma attack: a prospective cohort study about characteristics and response to emergency department treatment. Chest 118:1547\u20131552","journal-title":"Chest"},{"key":"682_CR178","doi-asserted-by":"crossref","unstructured":"Edmonds ML, Camargo CA Jr, Pollack CV Jr, Rowe BH (2003) Early use of inhaled corticosteroids in the emergency department treatment of acute asthma. Cochrane Database Syst Rev CD002308","DOI":"10.1002\/14651858.CD002308"},{"key":"682_CR179","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.pupt.2005.09.003","volume":"19","author":"A Franco Di","year":"2006","unstructured":"Di Franco A, Bacci E, Bartoli ML, Cianchetti S, Dente FL, Taccola M, Vagaggini B, Zingoni M, Paggiaro PL (2006) Inhaled fluticasone propionate is effective as well as oral prednisone in reducing sputum eosinophilia during exacerbations of asthma which do not require hospitalization. Pulm Pharmacol Ther 19:353\u2013360","journal-title":"Pulm Pharmacol Ther"},{"key":"682_CR180","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1136\/thx.51.11.1087","volume":"51","author":"ML Levy","year":"1996","unstructured":"Levy ML, Stevenson C, Maslen T (1996) Comparison of short courses of oral prednisolone and fluticasone propionate in the treatment of adults with acute exacerbations of asthma in primary care. Thorax 51:1087\u20131092","journal-title":"Thorax"},{"key":"682_CR181","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1378\/chest.117.2.440","volume":"117","author":"A Foresi","year":"2000","unstructured":"Foresi A, Morelli MC, Catena E (2000) Low-dose budesonide with the addition of an increased dose during exacerbations is effective in long-term asthma control. On behalf of the Italian Study Group. Chest 117:440\u2013446","journal-title":"Chest"},{"key":"682_CR182","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1183\/09031936.06.00105305","volume":"28","author":"HK Reddel","year":"2006","unstructured":"Reddel HK, Barnes DJ (2006) Pharmacological strategies for self-management of asthma exacerbations. Eur Respir J 28:182\u2013199","journal-title":"Eur Respir J"},{"key":"682_CR183","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1164\/ajrccm.165.5.2109093","volume":"165","author":"F Maltais","year":"2002","unstructured":"Maltais F, Ostinelli J, Bourbeau J, Tonnel AB, Jacquemet N, Haddon J, Rouleau M, Boukhana M, Martinot JB, Duroux P (2002) Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. Am J Respir Crit Care Med 165:698\u2013703","journal-title":"Am J Respir Crit Care Med"},{"key":"682_CR184","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1164\/ajrccm.156.6.9703003","volume":"156","author":"R Donnelly","year":"1997","unstructured":"Donnelly R, Williams KM, Baker AB, Badcock CA, Day RO, Seale JP (1997) Effects of budesonide and fluticasone on 24-hour plasma cortisol. A dose-response study. Am J Respir Crit Care Med 156:1746\u20131751","journal-title":"Am J Respir Crit Care Med"},{"key":"682_CR185","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/thx.51.3.262","volume":"51","author":"DJ Clark","year":"1996","unstructured":"Clark DJ, Grove A, Cargill RI, Lipworth BJ (1996) Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients. Thorax 51:262\u2013266","journal-title":"Thorax"},{"key":"682_CR186","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/adc.88.6.554","volume":"88","author":"GR Todd","year":"2003","unstructured":"Todd GR (2003) Adrenal crisis due to inhaled steroids is underestimated. Arch Dis Child 88:554\u2013555","journal-title":"Arch Dis Child"},{"key":"682_CR187","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/adc.87.6.457","volume":"87","author":"GR Todd","year":"2002","unstructured":"Todd GR, Acerini CL, Ross-Russell R, Zahra S, Warner JT, McCance D (2002) Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Arch Dis Child 87:457\u2013461","journal-title":"Arch Dis Child"},{"key":"682_CR188","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1056\/NEJM199707033370102","volume":"337","author":"RG Cumming","year":"1997","unstructured":"Cumming RG, Mitchell P, Leeder SR (1997) Use of inhaled corticosteroids and the risk of cataracts. N Engl J Med 337:8\u201314","journal-title":"N Engl J Med"},{"key":"682_CR189","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/jama.1997.03540330044033","volume":"277","author":"E Garbe","year":"1997","unstructured":"Garbe E, LeLorier J, Boivin JF, Suissa S (1997) Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma. JAMA 277:722\u2013727","journal-title":"JAMA"},{"key":"682_CR190","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(00)02138-3","volume":"355","author":"CA Wong","year":"2000","unstructured":"Wong CA, Walsh LJ, Smith CJ, Wisniewski AF, Lewis SA, Hubbard R, Cawte S, Green DJ, Pringle M, Tattersfield AE (2000) Inhaled corticosteroid use and bone-mineral density in patients with asthma. Lancet 355:1399\u20131403","journal-title":"Lancet"},{"key":"682_CR191","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2165\/00002018-200629070-00005","volume":"29","author":"S Pedersen","year":"2006","unstructured":"Pedersen S (2006) Clinical safety of inhaled corticosteroids for asthma in children: an update of long-term trials. Drug Saf 29:599\u2013612","journal-title":"Drug Saf"},{"key":"682_CR192","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/thorax.56.4.272","volume":"56","author":"AE Tattersfield","year":"2001","unstructured":"Tattersfield AE, Town GI, Johnell O, Picado C, Aubier M, Braillon P, Karlstrom R (2001) Bone mineral density in subjects with mild asthma randomised to treatment with inhaled corticosteroids or non-corticosteroid treatment for two years. Thorax 56:272\u2013278","journal-title":"Thorax"},{"key":"682_CR193","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1067\/mai.2003.4","volume":"111","author":"S Elmstahl","year":"2003","unstructured":"Elmstahl S, Ekstrom H, Galvard H, Johnell O, Gerhardsson de Verdier M, Norjavaara E (2003) Is there an association between inhaled corticosteroids and bone density in postmenopausal women? J Allergy Clin Immunol 111:91\u201396","journal-title":"J Allergy Clin Immunol"},{"key":"682_CR194","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1542\/peds.2007-3381","volume":"122","author":"HW Kelly","year":"2008","unstructured":"Kelly HW, Van Natta ML, Covar RA, Tonascia J, Green RP, Strunk RC (2008) Effect of long-term corticosteroid use on bone mineral density in children: a prospective longitudinal assessment in the childhood Asthma Management Program (CAMP) study. Ped 122:e53\u2013e61","journal-title":"Ped"},{"key":"682_CR195","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1359\/jbmr.2001.16.3.581","volume":"16","author":"TP Staa van","year":"2001","unstructured":"van Staa TP, Leufkens HG, Cooper C (2001) Use of inhaled corticosteroids and risk of fractures. J Bone Miner Res 16:581\u2013588","journal-title":"J Bone Miner Res"},{"key":"682_CR196","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1164\/rccm.200305-640OC","volume":"169","author":"S Suissa","year":"2004","unstructured":"Suissa S, Baltzan M, Kremer R, Ernst P (2004) Inhaled and nasal corticosteroid use and the risk of fracture. Am J Respir Crit Care Med 169:83\u201388","journal-title":"Am J Respir Crit Care Med"},{"key":"682_CR197","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.amjmed.2004.05.021","volume":"117","author":"TA Lee","year":"2004","unstructured":"Lee TA, Weiss KB, Sullivan SD (2004) Cost-effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease. Am J Med 117:618\u2013619","journal-title":"Am J Med"},{"key":"682_CR198","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2165\/00002018-200831050-00005","volume":"31","author":"M Etminan","year":"2008","unstructured":"Etminan M, Sadatsafavi M, Ganjizadeh ZS, Takkouche B, Fitzgerald JM (2008) Inhaled corticosteroids and the risk of fractures in older adults: a systematic review and meta-analysis. Drug Saf 31:409\u2013414","journal-title":"Drug Saf"},{"key":"682_CR199","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1378\/chest.129.1.15","volume":"129","author":"HS Nelson","year":"2006","unstructured":"Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM (2006) The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 129:15\u201326","journal-title":"Chest"},{"key":"682_CR200","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1056\/NEJMp0810561","volume":"360","author":"JM Kramer","year":"2009","unstructured":"Kramer JM (2009) Balancing the benefits and risks of inhaled long-acting beta-agonists-the influence of values. N Engl J Med 360:1592\u20131595","journal-title":"N Engl J Med"},{"key":"682_CR201","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.4049\/jimmunol.171.6.3245","volume":"171","author":"MJ Paul-Clark","year":"2003","unstructured":"Paul-Clark MJ, Roviezzo F, Flower RJ, Cirino G, Soldato PD, Adcock IM, Perretti M (2003) Glucocorticoid receptor nitration leads to enhanced anti-inflammatory effects of novel steroid ligands. J Immunol 171:3245\u20133252","journal-title":"J Immunol"},{"key":"682_CR202","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.pupt.2004.04.002","volume":"17","author":"BJ Nevin","year":"2004","unstructured":"Nevin BJ, Broadley KJ (2004) Comparative effects of inhaled budesonide and the NO-donating budesonide derivative, NCX 1020, against leukocyte influx and airway hyperreactivity following lipopolysaccharide challenge. Pulm Pharmacol Ther 17:219\u2013232","journal-title":"Pulm Pharmacol Ther"},{"key":"682_CR203","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0140-6736(08)61449-X","volume":"372","author":"IM Adcock","year":"2008","unstructured":"Adcock IM, Caramori G, Chung KF (2008) New targets for drug development in asthma. Lancet 372:1073\u20131087","journal-title":"Lancet"},{"key":"682_CR204","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1177\/0091270007299763","volume":"47","author":"H Derendorf","year":"2007","unstructured":"Derendorf H (2007) Pharmacokinetic and pharmacodynamic properties of inhaled ciclesonide. J Clin Pharmacol 47:782\u2013789","journal-title":"J Clin Pharmacol"},{"key":"682_CR205","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.mce.2007.05.014","volume":"275","author":"H Schacke","year":"2007","unstructured":"Schacke H, Berger M, Rehwinkel H, Asadullah K (2007) Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index. Mol Cell Endocrinol 275:109\u2013117","journal-title":"Mol Cell Endocrinol"},{"key":"682_CR206","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1073\/pnas.0300372101","volume":"101","author":"H Schacke","year":"2004","unstructured":"Schacke H, Schottelius A, Docke WD, Strehlke P, Jaroch S, Schmees N, Rehwinkel H, Hennekes H, Asadullah K (2004) Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects. Proc Natl Acad Sci USA 101:227\u2013232","journal-title":"Proc Natl Acad Sci USA"},{"key":"682_CR207","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0163-7258(02)00297-8","volume":"96","author":"H Schacke","year":"2002","unstructured":"Schacke H, Docke WD, Asadullah K (2002) Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther 96:23\u201343","journal-title":"Pharmacol Ther"},{"key":"682_CR208","doi-asserted-by":"crossref","first-page":"19244","DOI":"10.1073\/pnas.0705517104","volume":"104","author":"JN Miner","year":"2007","unstructured":"Miner JN, Ardecky B, Benbatoul K, Griffiths K, Larson CJ, Mais DE, Marschke K, Rosen J, Vajda E, Zhi L et al (2007) Antiinflammatory glucocorticoid receptor ligand with reduced side effects exhibits an altered protein-protein interaction profile. Proc Natl Acad Sci USA 104:19244\u201319249","journal-title":"Proc Natl Acad Sci USA"},{"key":"682_CR209","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2005.06.029","volume":"122","author":"S Ogawa","year":"2005","unstructured":"Ogawa S, Lozach J, Benner C, Pascual G, Tangirala RK, Westin S, Hoffmann A, Subramaniam S, David M, Rosenfeld MG et al (2005) Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell 122:707\u2013721","journal-title":"Cell"},{"key":"682_CR210","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.coph.2008.02.001","volume":"8","author":"SN Farrow","year":"2008","unstructured":"Farrow SN (2008) Nuclear receptors: doubling up in the lung. Curr Opin Pharmacol 8:275\u2013279","journal-title":"Curr Opin Pharmacol"},{"key":"682_CR211","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1183\/09031936.00036707","volume":"31","author":"T Renda","year":"2008","unstructured":"Renda T, Baraldo S, Pelaia G, Bazzan E, Turato G, Papi A, Maestrelli P, Maselli R, Vatrella A, Fabbri LM et al (2008) Increased activation of p38 MAPK in COPD. Eur Respir J 31:62\u201369","journal-title":"Eur Respir J"},{"key":"682_CR212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.106.111674","volume":"321","author":"K Ito","year":"2007","unstructured":"Ito K, Caramori G, Adcock IM (2007) Therapeutic potential of phosphatidylinositol 3-kinase inhibitors in inflammatory respiratory disease. J Pharmacol Exp Ther 321:1\u20138","journal-title":"J Pharmacol Exp Ther"},{"key":"682_CR213","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0140-6736(08)61449-X","volume":"372","author":"IM Adcock","year":"2008","unstructured":"Adcock IM, Caramori G, Chung KF (2008) New targets for drug development in asthma. Lancet 372:1073\u20131087","journal-title":"Lancet"},{"key":"682_CR214","first-page":"A333","volume":"5","author":"JA Marwick","year":"2008","unstructured":"Marwick JA, Stevenson CS, Barnes PJ, Ito K, Adcock IM, Kirkham PA (2008) Cigarette smoke reduces steroid sensitivity by reducing glucocorticoid receptor (GR) and GR co-repressor expression. Proc Am Thorac Soc 5:A333","journal-title":"Proc Am Thorac Soc"},{"key":"682_CR215","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1067\/mai.2002.122465","volume":"109","author":"E Irusen","year":"2002","unstructured":"Irusen E, Matthews JG, Takahashi A, Barnes PJ, Chung KF, Adcock IM (2002) p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma. J Allergy Clin Immunol 109:649\u2013657","journal-title":"J Allergy Clin Immunol"},{"key":"682_CR216","doi-asserted-by":"crossref","unstructured":"Kent L, Smyth L, Plumb J, Clayton C, Fox S, Ray D, Farrow S, Singh D (2008) Inhibition of LPS stimulated COPD macrophage inflammatory gene expression by dexamethasone and the p38 MAPK inhibitor SB706504. J Pharmacol Exp Ther. doi: 10.1124\/jpet.108.142950","DOI":"10.1124\/jpet.108.142950"},{"key":"682_CR217","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jaci.2006.04.055","volume":"118","author":"TK Loke","year":"2006","unstructured":"Loke TK, Mallett KH, Ratoff J, O\u2019Connor BJ, Ying S, Meng Q, Soh C, Lee TH, Corrigan CJ (2006) Systemic glucocorticoid reduces bronchial mucosal activation of activator protein 1 components in glucocorticoid-sensitive but not glucocorticoid-resistant asthmatic patients. J Allergy Clin Immunol 118:368\u2013375","journal-title":"J Allergy Clin Immunol"},{"key":"682_CR218","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1084\/jem.20040416","volume":"200","author":"BG Cosio","year":"2004","unstructured":"Cosio BG, Tsaprouni L, Ito K, Jazrawi E, Adcock IM, Barnes PJ (2004) Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages. J Exp Med 200:689\u2013695","journal-title":"J Exp Med"},{"key":"682_CR219","first-page":"470","volume":"9","author":"T Ahmad","year":"2008","unstructured":"Ahmad T, Barnes PJ, Adcock IM (2008) Overcoming steroid insensitivity in smoking asthmatics. Curr Opin Investig Drugs 9:470\u2013477","journal-title":"Curr Opin Investig Drugs"},{"key":"682_CR220","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1183\/09031936.06.00053805","volume":"28","author":"I Rahman","year":"2006","unstructured":"Rahman I, Adcock IM (2006) Oxidative stress and redox regulation of lung inflammation in COPD. Eur Respir J 28:219\u2013242","journal-title":"Eur Respir J"},{"key":"682_CR221","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/ebm.13.3.76","volume":"13","author":"BM Rothschild","year":"2008","unstructured":"Rothschild BM (2008) Review: individual DMARDs have similar efficacy for RA, but combination therapy improves response. Evid Based Med 13:76","journal-title":"Evid Based Med"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-009-0682-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-009-0682-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-009-0682-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T09:58:32Z","timestamp":1739181512000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-009-0682-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,26]]},"references-count":221,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["682"],"URL":"https:\/\/doi.org\/10.1007\/s00228-009-0682-z","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,26]]}}}